The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Abstract
Preface. List of examples. 1. Introduction. 1.1 What are Bayesian methods? 1.2 What do we mean by 'health--care evaluation'? 1.3 A Bayesian approach to evaluation. 1.4 The aim of this book and the intended audience. 1.5 Structure of the book. 2. Basic Concepts from Traditional Statistical Analysis. 2.1 Probability. 2.1.1 What is probability? 2.1.2 Odds and log--odds. 2.1.3 Bayes theorem for simple events. 2.2 Random variables, parameters and likelihood. 2.2.1 Random variables and their distributions. 2.2.2 Expectation, variance, covariance and correlation. 2.2.3 Parametric distributions and conditional independence. 2.2.4 Likelihoods. 2.3 The normal distribution. 2.4 Normal likelihoods. 2.4.1 Normal approximations for binary data. 2.4.2 Normal likelihoods for survival data. 2.4.3 Normal likelihoods for count responses. 2.4.4 Normal likelihoods for continuous responses. 2.5 Classical inference. 2.6 A catalogue of useful distributionsaeo. 2.6.1 Binomial and Bernoulli. 2.6.2 Poisson. 2.6.3 Beta. 2.6.4 Uniform. 2.6.5 Gamma. 2.6.6 Root--inverse--gamma. 2.6.7 Half--normal. 2.6.8 Log--normal. 2.6.9 Student's t. 2.6.10 Bivariate normal. 2.7 Key points. Exercises. 3. An Overview of the Bayesian Approach. 3.1 Subjectivity and context. 3.2 Bayes theorem for two hypotheses. 3.3 Comparing simple hypotheses: likelihood ratios and Bayes factors. 3.4 Exchangeability and parametric modellingaeo. 3.5 Bayes theorem for general quantities. 3.6 Bayesian analysis with binary data. 3.6.1 Binary data with a discrete prior distribution. 3.6.2 Conjugate analysis for binary data. 3.7 Bayesian analysis with normal distributions. 3.8 Point estimation, interval estimation and interval hypotheses. 3.9 The prior distribution. 3.10 How to use Bayes theorem to interpret trial results. 3.11 The 'credibility' of significant trial resultsaeo. 3.12 Sequential use of Bayes theoremaeo. 3.13 Predictions. 3.13.1 Predictions in the Bayesian framework. 3.13.2 Predictions for binary dataaeo. 3.13.3 Predictions for normal data. 3.14 Decision--making. 3.15 Design. 3.16 Use of historical data. 3.17 Multiplicity, exchangeability and hierarchical models. 3.18 Dealing with nuisance parametersaeo. 3.18.1 Alternative methods for eliminating nuisance parametersaeo. 3.18.2 Profile likelihood in a hierarchical modelaeo. 3.19 Computational issues. 3.19.1 Monte Carlo methods. 3.19.2 Markov chain Monte Carlo methods. 3.19.3 WinBUGS. 3.20 Schools of Bayesians. 3.21 A Bayesian checklist. 3.22 Further reading. 3.23 Key points. Exercises. 4. Comparison of Alternative Approaches to Inference. 4.1 A structure for alternative approaches. 4.2 Conventional statistical methods used in health--care evaluation. 4.3 The likelihood principle, sequential analysis and types of error. 4.3.1 The likelihood principle. 4.3.2 Sequential analysis. 4.3.3 Type I and Type II error. 4.4 P--values and Bayes factorsaeo. 4.4.1 Criticism of P--values. 4.4.2 Bayes factors as an alternative to P--values: simple hypotheses. 4.4.3 Bayes factors as an alternative to P--values: composite hypotheses. 4.4.4 Bayes factors in preference studies. 4.4.5 Lindley's paradox. 4.5 Key points. Exercises. 5. Prior Distributions. 5.1 Introduction. 5.2 Elicitation of opinion: a brief review. 5.2.1 Background to elicitation. 5.2.2 Elicitation techniques. 5.2.3 Elicitation from multiple experts. 5.3 Critique of prior elicitation. 5.4 Summary of external evidenceaeo. 5.5 Default priors. 5.5.1 'Non--informative' or 'reference' priors: 5.5.2 'Sceptical' priors. 5.5.3 'Enthusiastic' priors. 5.5.4 Priors with a point mass at the null hypothesis ('lump--and--smear' priors)aeo. 5.6 Sensitivity analysis and 'robust' priors. 5.7 Hierarchical priors. 5.7.1 The judgement of exchangeability. 5.7.2 The form for the random--effects distribution. 5.7.3 The prior for the standard deviation of the random effectsaeo. 5.8 Empirical criticism of priors. 5.9 Key points. Exercises. 6. Randomised Controlled Trials. 6.1 Introduction. 6.2 Use of a loss function: is a clinical trial for inference or decision? 6.3 Specification of null hypotheses. 6.4 Ethics and randomisation: a brief review. 6.4.1 Is randomisation necessary? 6.4.2 When is it ethical to randomise? 6.5 Sample size of non--sequential trials. 6.5.1 Alternative approaches to sample--size assessment. 6.5.2 'Classical power': hybrid classical--Bayesian methods assuming normality. 6.5.3 'Bayesian power'. 6.5.4 Adjusting formulae for different hypotheses. 6.5.5 Predictive distribution of power and necessary sample size. 6.6 Monitoring of sequential trials. 6.6.1 Introduction. 6.6.2 Monitoring using the posterior distribution. 6.6.3 Monitoring using predictions: 'interim power'. 6.6.4 Monitoring using a formal loss function. 6.6.5 Frequentist properties of sequential Bayesian methods. 6.6.6 Bayesian methods and data monitoring committees. 6.7 The role of 'scepticism' in confirmatory studies. 6.8 Multiplicity in randomised trials. 6.8.1 Subset analysis. 6.8.2 Multi--centre analysis. 6.8
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–287 of 287
Methods for Assessing the Credibility of Clinical Trial Outcomes
Matthews, R. (2001) · Drug Information Journal · doi:10.1177/009286150103500442 · Cited by 60
Kadane, J. B. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00072-0 · Cited by 59
How Large Should a Clinical Trial Be?
Gittins, J. C., & Pezeshk, H. (2000) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.1111/1467-9884.00228 · Cited by 59
Projection from previous studies: A Bayesian and frequentist compromise
Brown, B. W., Herson, J., Atkinson, E. N., & Rozell, M. E. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90023-7 · Cited by 59
On the Allocation of Treatments in Sequential Medical Trials
Bather, J. A. (1985) · International Statistical Review · doi:10.2307/1402870 · Cited by 59
Selecting Treatments: A Decision Theoretic Approach
Claxton, K., Lacey, L. F., & Walker, S. G. (2000) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/1467-985x.00166 · Cited by 58
Using empirical bayes methods in biopharmaceutical research
Louis, T. A. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100604 · Cited by 58
Optimal Bayesian Randomization
Berry, S. M., & Kadane, J. B. (1997) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/1467-9868.00098 · Cited by 57
Data Monitoring Committees and Interim Monitoring Guidelines
Freidlin, B., Korn, E. L., & George, S. L. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00017-3 · Cited by 57
Helping doctors to draw appropriate inferences from the analysis of medical studies
Burton, P. R. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131702 · Cited by 53
Detsky, A. S. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90118-3 · Cited by 51
Early Stopping of a Clinical Trial When There is Evidence of No Treatment Benefit
Dignam, J. J., Bryant, J., Wieand, H. S., Fisher, B., & Wolmark, N. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00041-5 · Cited by 50
Assessing Uncertainty in Cost-Effectiveness Analyses
Parmigiani, G., Samsa, G., Ancukiewicz, M., et al. (1997) · Medical Decision Making · doi:10.1177/0272989x9701700404 · Cited by 50
Approximate Bayesian inference for random effects meta-analysis
Abrams, K. R., & Sansó, B. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980130)17:2<201::aid-sim736>3.0.co;2-9 · Cited by 50
Self-citationWhat is the prior probability of a proposed new treatment being superior to established treatments?
Chalmers, I. (1997) · BMJ · doi:10.1136/bmj.314.7073.74a · Cited by 48
On Bayesian Methods for Bioequivalence
Selwyn, M. R., & Hall, N. (1984) · Biometrics · doi:10.2307/2531161 · Cited by 48
Sample size calculation for clinical trials: the impact of clinician beliefs
Fayers, P. M., Cuschieri, A., Fielding, J. W. L., Craven, J., Uscinska, B., & Freedman, L. S. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0902 · Cited by 47
Hierarchical Selection Models With Applications in Meta-Analysis
Silliman, N. (1997) · Journal of the American Statistical Association · doi:10.1080/01621459.1997.10474047 · Cited by 47
Application of bayesian statistics to decision making during a clinical trial
Freedman, L. S., & Spiegelhalter, D. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110105 · Cited by 45
Self-citationReporting bayesian analyses of clinical trials
Hughes, M. D. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121802 · Cited by 45
Craig, B. Α., Fryback, D. G., Klein, R., & Klein, B. E. K. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990615)18:11<1355::aid-sim130>3.0.co;2-k · Cited by 44
Small clinical trials: Are they all bad?
Matthews, J. N. S. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140204 · Cited by 44
Bayesian interpretation of trials: the example of intrapartum electronic fetal heart rate monitoring
Hornbuckle, J., Vail, A., Abrams, K. R., & Thornton, J. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11571.x · Cited by 44
Self-citationThe probability of cost-effectiveness
O’Hagan, A., & Stevens, J. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-5 · Cited by 44
Use of Bayesian Markov Chain Monte Carlo Methods to Model Cost-of-Illness Data
Cooper, N. J., Sutton, A. J., Mugford, M., & Abrams, K. R. (2003) · Medical Decision Making · doi:10.1177/0272989x02239653 · Cited by 42
Self-citationA Bayesian strategy for screening cancer treatments prior to phase II clinical evaluation.
Thall, P., & Estey, E. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121303 · Cited by 42
Raghunathan, T. E., & Siscovick, D. S. (1996) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2986092 · Cited by 42
A Bayesian approach to the interpretation of subgroup results in clinical trials
Donner, A. P. (1982) · Journal of Chronic Diseases · doi:10.1016/0021-9681(82)90057-1 · Cited by 41
Decision analysis and bioequivalence trials
Lindley, D. V. (1998) · Statistical Science · doi:10.1214/ss/1028905932 · Cited by 41
Tan, S. B., Chung, Y. F. A., Tai, B., Cheung, Y., & Machin, D. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00318-5 · Cited by 40
Ethical considerations concerning treatment allocation in drug development trials
Senn, S. J. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm299ra · Cited by 39
Charts for the early stopping of pilot studies.
Mehta, C. R., & Cain, K. C. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.6.676 · Cited by 38
The future of biostatistics: expecting the unexpected
van Houwelingen, H. C. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19971230)16:24<2773::aid-sim761>3.0.co;2-q · Cited by 38
Comments on Bayesian and frequentist analysis and interpretation of clinical trials
Fisher, L. D. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00043-8 · Cited by 38
Computer-modeling and Graphical Strategies for Meta-analysis
DuMouchel, W., & Normand, S. T. (2000) · Chapman & Hall/CRC biostatistics series · doi:10.1201/9780203909935.ch6 · Cited by 38
Bayesian analyses of two-treatment crossover studies
Grieve, A. P. (1994) · Statistical Methods in Medical Research · doi:10.1177/096228029400300406 · Cited by 37
Assessing Placebo Response Using Bayesian Hierarchical Survival Models
Stangl, D. K., & Greenhouse, J. B. (1998) · Lifetime Data Analysis · doi:10.1023/a:1009644308160 · Cited by 36
The case for frequentism in clinical trials
Whitehead, J. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121506 · Cited by 36
Implications for trials in progress of publication of positive results
FLETCHER, A. E., Spiegelhalter, D. J., Staessen, J. A., Thijs, L., & Bulpitt, C. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91762-b · Cited by 35
Self-citationEstimating treatment effects in clinical crossover trials
Grieve, A. P., & Senn, S. J. (1998) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543409808835233 · Cited by 35
A unified method for monitoring and analysing controlled trials
Grossman, J., Parmar, M., Spiegelhalter, D. J., & Freedman, L. S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131804 · Cited by 34
Self-citationPalmer, C. R. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm298ra · Cited by 34
Carlin, B. P., Chaloner, K. M., Church, T. R., Louis, T. A., & Matts, J. P. (1993) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348470 · Cited by 34
Simes, R. J. (1986) · Statistics in Medicine · doi:10.1002/sim.4780050505 · Cited by 33
A Bayesian group sequential design for a multiple arm randomized clinical trial
Rosner, G. L., & Berry, D. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140405 · Cited by 32
Evaluating the NHS research and development programme: will the programme give value for money?
Buxton, M. J., & Hanney, S. (1998) · Journal of the Royal Society of Medicine · doi:10.1177/014107689809135s02 · Cited by 31
Some practical aspects of the interim monitoring of clinical trials
Simon, R. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131315 · Cited by 31
Bayesian analysis of case‐control studies
Marshall, R. J. (1988) · Statistics in Medicine · doi:10.1002/sim.4780071203 · Cited by 31
Decision analysis and Bayesian methods in clinical trials
Berry, D. A. (1995) · Cancer treatment and research · doi:10.1007/978-1-4615-2009-2_7 · Cited by 29
Cronin, K. A., Legler, J. M., & Etzioni, R. (1998) · Statistics in Medicine · Cited by 29
Using databases to evaluate therapy
Hlatky, M. A. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100415 · Cited by 29
Sensitivity of Bayes Inference with Data-Dependent Stopping Rules
Rosenbaum, P. R., & Rubin, D. B. (1984) · The American Statistician · doi:10.1080/00031305.1984.10483176 · Cited by 29
A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer
Tan, S.-B., Machin, D., Tai, B.-C., Foo, K., & Tan, E. H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600199 · Cited by 27
Generalized synthesis of evidence and the threat of dissemination bias
Sutton, A. J., Abrams, K. R., & Jones, D. R. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00460-2 · Cited by 27
Self-citationPassive smoking in the workplace: classical and Bayesian meta-analyses
Biggerstaff, B. J., Tweedie, R. L., & Mengersen, K. L. (1994) · International Archives of Occupational and Environmental Health · doi:10.1007/bf00454366 · Cited by 27
Empirical Bayes Methods in Clinical Trials Meta‐Analysis
Stijnen, T., & van Houwelingen, H. C. (1990) · Biometrical Journal · doi:10.1002/bimj.4710320316 · Cited by 27
Simple Bayesian analysis in clinical trials: A tutorial
Abrams, K. R., Ashby, D., & Errington, D. (1994) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)90032-9 · Cited by 25
Self-citationInference and decision in clinical trials
Armitage, P. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90033-4 · Cited by 25
The dangers of inferring treatment effects from observational data
Dunn, D. T., Babiker, A. G., Hooker, M., & Darbyshire, J. H. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00200-8 · Cited by 23
Prospective application of Bayesian monitoring and analysis in an ‘open’ randomized clinical trial
Vail, A., Hornbuckle, J., Spiegelhalter, D. J., & Thornton, J. (2001) · Statistics in Medicine · doi:10.1002/sim.1171 · Cited by 23
Self-citationDisease mapping using empirical bayes and bayes methods on mortality statistics in the Netherlands
Heisterkamp, S. H., Doornbos, G., & Gankema, M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121915 · Cited by 22
Problems of multiplicity in clinical trials
Simon, R. M. (1994) · Journal of Statistical Planning and Inference · doi:10.1016/0378-3758(94)90197-x · Cited by 21
A Hierarchical Bayesian Model for Combining Multiple 2 × 2 Tables Using Conditional Likelihoods
Liao, J. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00268.x · Cited by 20
Data monitoring committees and problems of lower-than-expected accrual or event rates
Korn, E. L., & Simon, R. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00088-8 · Cited by 20
Bayesian Methods in Phase III Trials
Berry, D. A. (1991) · Drug Information Journal · doi:10.1177/009286159102500306 · Cited by 19
Bayesian Communication: A Clinically Significant Paradigm for Electronic Publication
Lehmann, H. P., & Goodman, S. N. (2000) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2000.0070254 · Cited by 18
Henderson, W. G., MORITZ, T. E., Goldman, S. M., Copeland, J. G., & Sethi, G. K. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00071-2 · Cited by 18
Chelimsky, E., Silberman, G., & Droitcour, J. A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90253-d · Cited by 17
Correlations in Uncertainty Analysis for Medical Decision Making
Chessa, A. G., Dekker, R., Vliet, B. V., Steyerberg, E. W., & Habbema, J. D. F. (1999) · Medical Decision Making · doi:10.1177/0272989x9901900306 · Cited by 17
INTRODUCTION TO BAYESIAN REASONING
Hornberger, J. M. (2001) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462301104022 · Cited by 16
Early termination of a phase II clinical trial
Hilsenbeck, S. G. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90059-1 · Cited by 15
Meta-analysis of Clinical Trials: Opportunities and Limitations
Simon, R. (2000) · Chapman & Hall/CRC biostatistics series · doi:10.1201/9780203909935.ch13 · Cited by 15
The Ethics of Randomised Controlled Trials: A Matter of Statistical Belief?
Hutton, J. L. (1996) · Health Care Analysis · doi:10.1007/bf02251209 · Cited by 14
Adjustment for Publication Bias and Quality Bias in Bayesian Meta-analysis
Tweedie, R. L., Smith, D. D., & Givens, G. H. (2000) · Chapman & Hall/CRC biostatistics series · doi:10.1201/9780203909935.ch12 · Cited by 11
A Bayesian Approach to the Analysis of Binary Crossover Data
Forster, J. J. (1994) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348932 · Cited by 10
Stopping a clinical trial very early because of toxicity: Summarizing the evidence
Korn, E. L., Yu, K. F., & Miller, L. L. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90226-4 · Cited by 10
Extending a Bayesian Analysis of the Two-Period Crossover to Accommodate Missing Data
Grieve, A. P. (1995) · Biometrika · doi:10.1093/biomet/82.2.277 · Cited by 10
Combining Event Rates from Clinical Trials: Comparison of Bayesian and Classical Methods
Su, X. Y., & Po, A. L. W. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000504 · Cited by 9
Monitoring randomised controlled trials
Abrams, K. R. (1998) · BMJ · doi:10.1136/bmj.316.7139.1183 · Cited by 9
Self-citationA Physician-Based Architecture for the Construction and Use of Statistical Models
Shachter, R. D., & Lehmann, H. P. (1994) · Methods of Information in Medicine · doi:10.1055/s-0038-1635035 · Cited by 8
Bayesian approach for meta - analysis of controlled clinical trials
Rogatko, A. (1992) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929208830857 · Cited by 8
Likelihood and clinical trials
Hill, G. B., Forbes, W., Kozak, J., & MacNeill, I. B. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00156-0 · Cited by 7
Evaluation of bioequivalence studies
Grieve, A. P., & Pabst, G. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280080 · Cited by 4
Comparative Statistical Inference (2nd Edition)
Unwin, A. R., & Barnett, V. (1983) · Journal of the Operational Research Society · doi:10.1057/jors.1983.40 · Cited by 4
O’Brien, P. C. (2005) · Wiley eBooks · doi:10.1002/0470011815.b2a01018 · Cited by 4
Meta-analysis: formulating, evaluating, combining, and reporting
Normand, S.-L. T. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990215)18:3<321::aid-sim28>3.0.co;2-p
Senn (1998) · doi:10.1002/(sici)1097-0258(19980815/30)17:15/16
Cited by
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
The Handbook of Research Synthesis and Meta-Analysis
(2019) · doi:10.7758/9781610448864 · Cited by 4,553
Gelman, A. (2006) · Bayesian Analysis · doi:10.1214/06-ba117a · Cited by 4,050
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Maron, D. J., Hochman, J. S., Reynolds, H. R., Bangalore, S., O’Brien, S. M., Boden, W. E., Chaitman, B. R., Senior, R., López-Sendón, J., Alexander, K. P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915922 · Cited by 2,449
Analysing data and undertaking meta‐analyses
Deeks, J. J., Higgins, J. P., Altman, D. G., & on behalf of the Cochrane Statistical Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch10 · Cited by 2,672
Metadata
- Authors
- Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P.
- Venue
- Wiley eBooks
- Publisher
- Wiley
- Published
- 2003-12-09
- Issue
- 1
- OpenAlex
- W1479881385
- Cited by
- 1,673
- References
- 287
- FWCI
- 8.71
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.